1-3 of 3
Duncan Murray
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes with single-agent gilteritinib for relapsed or refractory FLT3 -mutant AML after contemporary induction therapy

Clinical Trials & Observations
Jad Othman, Angela Hwang, Maximillian Brodermann, Islam Abdallah, Kayleigh McCloskey, Paolo Gallipoli, Georgina Clarke, Raymond Dang, Jennifer Vidler, Pramila Krishnamurthy, Faisal Basheer, Anne-Louise Latif, Renuka Palanicawandar, Tom Taylor, Asra Khan, Victoria Campbell, Francesca Hogan, Alex Kanellopoulos, Kathryn Fleming, Angela Collins, Chris Dalley, Justin Loke, Scott Marshall, David Taussig, Sreetharan Munisamy, Eleana Loizou, Heba Yassin, Mike Dennis, Rui Zhao, Edward Belsham, Duncan Murray, Nicole Fowler, Jenny O'Nions, Anjum Khan, Rob Sellar, Richard Dillon
Journal: Blood Advances
Blood Adv (2024) 8 (21): 5590–5597.
https://doi.org/10.1182/bloodadvances.2024014017
Published: 2024
Includes: Supplemental data
Journal Articles

Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR

Clinical Trials & Observations
Duncan Murray, Jack Luke McMurray, Suzy Eldershaw, Hayden Pearce, Nathaniel Davies, Julia J. Scarisbrick, Paul Moss
Journal: Blood Advances
Blood Adv (2019) 3 (4): 519–530.
https://doi.org/10.1182/bloodadvances.2018025114
Published: 2019
Includes: Supplemental data
Journal Articles

The number of CD56 dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT

Clinical Trials & Observations
Luke Maggs, Francesca Kinsella, Y. L. Tracey Chan, Suzy Eldershaw, Duncan Murray, Jane Nunnick, Joanne Bird, Charles Craddock, Jianmin Zuo, Ram Malladi, Paul Moss
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1589–1597.
https://doi.org/10.1182/bloodadvances.2017008631
Published: 2017
Includes: Supplemental data